LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease. The ...
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...
London, UK, 30 August 2024: The 2024 ESC Guidelines for the management of atrial fibrillation, developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), contain a ...
For patients with newly diagnosed atrial fibrillation, a quality improvement initiative improved access to specialist care ...
Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.
Atrial fibrillation (AFib) is a common type of irregular heartbeat that affects an estimated 5 million Americans. This condition, which causes the heart to beat chaotically and out of sync, can ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.
Data from more than 13,000 patients with AF show that the use of edoxaban over four years is associated with a low annualised rate of all-cause death, ischaemic stroke and major bleeding. 1, 2 The ...
The second focused update endorses dabigatran (Pradaxa), a new drug that like warfarin represents a first-line choice to prevent thromboembolism in AF. 2 The FDA approved dabigatran in October 2010.
Lone atrial fibrillation is a form of irregular heartbeat that can cause excessively fast beating. It only affects adults under 60 years old and can be asymptomatic or present symptoms, such as a ...
First introduced five decades ago, MRI scanners are now a cornerstone of modern medicine, vital for diagnosing strokes, tumors, spinal conditions and more, without ...